PatentS

---

• Class II HMG-COA reductase inhibitors and methods of use. C. Stauffacher; M. Lipton; M. N. Seleem, T. Schmidt; N. Steussy, V. Rodwell. US Patent 9,073,832 (July 7, 2015) 
• Antimicrobial substituted thiazoles and methods of use. M. S. Cushman, M. N. Seleem, AS Mayhoub. US Patent 9,353,072 (May 31, 2016) 
• Class II HMG-COA reductase inhibitors and methods of use  C. Stauffacher; M. Lipton; M. N. Seleem, T. Schmidt; N. Steussy, V. Rodwell. US Patent 9,604,925 (March 28, 2017) 
• Antimicrobial substituted thiazoles and methods of use. M. S. Cushman, M. N. Seleem, AS Mayhoub. US Patent 9,801,861 (October 31, 2017) 
• Lactones. (2018). M. Dai, M. N. Seleem, X. Yin. US Patent 10,087,190 (October 2, 2018) 
• Lactones. (2018). M. Dai, M. N. Seleem, X. Yin. US Patent 10,138,252 (November 27, 2018) 
• Aryl isonitriles as a new class of antimicrobial compounds. M. N. Seleem, M. Dai, D. C. Davis, H.T. Mohammad. US Patent 10,364,224 (July 2019) 
• Phenylthiazoles and uses thereof. Mark Cushman, A. Mayhoub, M. N. Seleem. US Patent 10,414,759 (September 2019) 
• Aryl isonitrile compounds as a new class of potent, broad-spectrum antifungal compounds. Kyei-Baffour; Kwaku, M. N. Seleem, Dai; Mingji, Mohammad; Haroon Taj. US Patent 10,449,174 (October 2019) 
• Aryl isonitriles as a new class of antimicrobial compounds. M. N. Seleem, M. Dai, D. C. Davis, H.T. Mohammad. US Patent 11,091,437 (October 2019) 
• Aryl isonitriles as a new class of antimicrobial compounds. M. N. Seleem, M. Dai, D. C. Davis, H.T. Mohammad. US Patent 11,098,014 (Nov 21, 2019) 
• Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections. M. N. Seleem. US Patent 10,301,664 (May 2019) 
• Cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptide. J. Chmielewski, M. N. Seleem. US Patent  10,265,408 (April 2019) 
• Cleavable conjugates of antibiotics and an antibacterial cell-penetrating peptide. J. Chmielewski, M. N. Seleem. US Patent 10,688,192 (June 2020) 
• Antibacterial cell-penetrating peptides. J. Chmielewski, M. N. Seleem. US Patent 10,875,895 (December 2020) 
• Method and device for annihilation of methicillin-resistant Staphylococcus aureus. Cheng; Ji-Xin, M. N. Seleem, Dong; Pu-Ting, Hui; Jie. USA Patent 11,013,933 (May 2021) 
• Aryl isonitriles as a new class of antimicrobial compounds. M. N. Seleem, M. Dai, D. C. Davis, H.T. Mohammad. US Patent 11,198,674 (December 2021) 
• Safer, potent, and fast acting antimicrobial agents. PV Ramachandran, M Seleem.US Patent App. 17/220,974 (2021). 
• Benzamide antibacterial agents. HO Sintim, M Seleem, C Opoku-Temeng, HT Mohammad, G Naclerio. US Patent App. 17/046,957. (2021).
• Diiodohydroxyquinoline for the treatment of clostridium difficile infection. M Seleem, N Abutaleb. US Patent App. 17/063,750. (2021). 
• Method for the determination of antibiotic susceptibility through stimulated Raman metabolic imaging. Ji-Xin Cheng, M. N. Seleem, HONG Weili. US Patent 11,231,371 (January 2022)
• Carbonic anhydrase inhibitors and antibiotics against multidrug resistant bacteria. DP Flaherty, M Seleem, J Kaur, X Cao. US Patent App. 17/415,899 (2022).
• Carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae infection DP Flaherty, M Seleem. US Patent App. 17/552,413 (2022).
• Method for the determination of antibiotic susceptibility through stimulated raman metabolic imaging. JX Cheng, M Seleem, H Weili. US Patent App. 17/548,483 (2023).
• 2023 US Patent# 11,731,964. Benzamide antibacterial agents.
• Diiodohydroxyquinoline for the treatment of clostridium difficile infection. M Seleem, N Abutaleb.  US Patent App. 18/387,450 (2024).